Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Cancer Research UK Scotland Institute in Glasgow is inviting applications for a postdoctoral scientist in tumour immunology, launching in March 2027 under a CRUK Career Development Fellowship.
You will lead innovative studies using in vivo cancer models, profiling tumor and immune microenvironments, and contribute to high-impact publications and collaborations.
The role offers relocation support and visa costs if required; closing date 4 December 2026.
The CRUK Scotland Institute is a cancer research institute, situated in Glasgow with approximately 250 researchers split across 30 research groups consisting of PIs, postdoctoral scientists, PhD students and scientific officers. It is one of Europe's leading cancer research centres, supporting cutting-edge work into the molecular mechanisms of cancer development. As well as core support from Cancer Research UK, the Institute also receives an additional third of its total income from external grants and industry collaborations. It has an excellent reputation for fundamental cancer research, including world-class metabolism studies and renowned in vivo modelling of tumour growth and metastasis.
Join the newly established laboratory of Dr Riccardo Mezzadra, launching in March 2027 and funded through a CRUK Career Development Fellowship. Dr Mezzadra's research focuses on understanding how conventional cancer therapies shape anti-tumour immune responses, with particular expertise in T cell immunology, tumour-immune interactions, and the use of advanced in vivo models to investigate mechanisms of anti-cancer immunity.
This is an exciting opportunity to become the first postdoctoral scientist in a growing research group investigating how conventional cancer therapies influence anti-tumour immunity and responses to immunotherapy. Working closely with the Group Leader, you will lead innovative studies combining in vivo cancer models, tumour and immune microenvironment profiling, genetic perturbation approaches, and functional screening strategies to address fundamental questions in cancer immunology.
Essential
Desirable
For informal enquiries, please email Dr Riccardo Mezzadra at riccardo.mezzadra@glasgow.ac.uk
Closing date: 4th December 2026
£39,253 to £45,505 subject to experience, plus relocation allowance and visa costs if required